MVision AI: your data is protected!
MVision AI not only provides unique AI-powered solutions for Radiotherapy treatment planning but also follows the highest standards of data protection for clinics and their…
Read more gbs
Cancer in Ireland – Raising Survival Rates
Every year, almost 45.000 people in Ireland are diagnosed with cancer, making Ireland the country with the highest cancer incidence in Europe. The 5 most…
Read more MVision’s GBS™ is Featured in 5 Posters at the German Society of Radiation Oncology (DEGRO) Annual Meeting
This week, we’re focusing on high-impact research presented during the German Society of Radiation Oncology (DEGRO) Annual Meeting. Five posters included a focus on MVision’s…
Read more Improving Tools to Fight Glioblastoma
Background Glioblastoma multiforme represents approximately half of the cases of central nervous system malignant tumors. The median age at diagnosis is 64 years, and the…
Read more MVision AI Receives FDA 510(k) Clearance for Guideline-Based Segmentation Radiotherapy Software
Helsinki, 31st of May, 2022 – MVision AI announces that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for guideline-based, AI-powered…
Read more